0 Commentarios
0 Acciones
1K Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
From Supportive Care to Gene Therapy: The Future of the Alveolar Capillary Dysplasia Treatment MarketAlveolar Capillary Dysplasia Treatment Market According to the latest report published by Data Bridge Market Research, the Alveolar Capillary Dysplasia Treatment Market alveolar capillary dysplasia treatment market size was valued at USD 21.14 million in 2025 and is expected to reach USD 32.93 million by 2033, at a CAGR of 5.70% during the forecast...0 Commentarios 0 Acciones 10 Views 0 Vista previa
-
Global Gene Therapy Platform Market Analysis: Key Players, Technology Innovations, and Strategic DevelopmentsThe global Gene Therapy Platform Market is witnessing significant growth as advancements in genetic engineering, molecular biology, and personalized medicine continue to transform the healthcare landscape. Gene therapy platforms provide essential technologies and tools that enable researchers and biotechnology companies to develop therapies designed to modify, replace, or regulate genes...0 Commentarios 0 Acciones 150 Views 0 Vista previa
-
How Gene Therapy Is Driving the Cystic Fibrosis MarketCystic Fibrosis Market According to the latest report published by Data Bridge Market Research, the Cystic Fibrosis Market cystic fibrosis market size was valued at USD 17.81 billion in 2025 and is expected to reach USD 155.97 billion by 2033, at a CAGR of 31.15% during the forecast period The market growth is largely fueled by advancements in precision...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Manufacturing Hope: How Cell and Gene Therapy Manufacturing Is Advancing with CDMO PartnershipsThe Cell and Gene Therapy CDMO Market is experiencing explosive growth as cell and gene therapy manufacturing continues to advance with strategic CDMO partnerships. According to market reports, the global Cell and Gene Therapy CDMO Market was valued at USD 27.34 billion in 2024 and is projected to reach USD 95.6 billion by 2032, exhibiting an impressive CAGR of 16.94% during the...0 Commentarios 0 Acciones 240 Views 0 Vista previa
-
Rare Genetic Disease Therapy Innovations: The Hurler Syndrome Treatment Market and Gene-Based ApproachesRare genetic diseases pose significant challenges for patients, families, and healthcare systems, requiring specialized knowledge, innovative therapies, and comprehensive care approaches. Hurler Syndrome, the most severe form of Mucopolysaccharidosis type I (MPS I), exemplifies both the devastating impact of these conditions and the remarkable progress being made in rare genetic disease...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
The Engine of Gene Therapy: How AAV Vector Manufacturing Is Powering Medical BreakthroughsThe field of gene therapy has witnessed remarkable progress, offering hope to patients with previously untreatable genetic disorders. At the heart of this revolution lies adeno-associated virus (AAV) vector manufacturing, a complex and highly specialized process that enables the delivery of therapeutic genes to target cells. According to the AAV Contract Development and Manufacturing...0 Commentarios 0 Acciones 321 Views 0 Vista previa
-
The Genetic Target: How Fibrodysplasia Ossificans Progressiva Therapy is Advancing with Gene-Based InnovationsFibrodysplasia ossificans progressiva (FOP) is one of the rarest and most disabling genetic disorders, characterized by the progressive formation of heterotopic bone in soft tissues, effectively turning muscles and connective tissue into a second skeleton. This devastating condition, caused by mutations in the ACVR1 gene, has long been without effective treatment. The Fibrodysplasia...0 Commentarios 0 Acciones 105 Views 0 Vista previa
-
Therapeutic Breakthroughs: How Cell and Gene Therapy Development Is AcceleratingThe Gene Therapy Clinical Trial Service Market is experiencing transformative growth as cell and gene therapy development continues to accelerate with specialized clinical trial services. According to market reports, the global Gene Therapy Clinical Trial Service Market was valued at USD 2.41 billion in 2024 and is projected to reach USD 42.94 billion by 2035, exhibiting an...0 Commentarios 0 Acciones 209 Views 0 Vista previa
-
Transfection Reagent Market to Reach USD 1.57 Billion by 2032, Driven by Gene Therapy and Biopharmaceutical InnovationGlobal transfection reagent market size was valued at USD 902.4 million in 2024. The market is projected to grow from USD 968.7 million in 2025 to USD 1.57 billion by 2032, exhibiting a CAGR of 7.2% during the forecast period. Transfection reagents are essential tools in molecular biology that enable the introduction of foreign nucleic acids into cells. These reagents facilitate gene expression...0 Commentarios 0 Acciones 196 Views 0 Vista previa
-
Transforming Biopharmaceutical Manufacturing Through the Cell and Gene Therapy CDMO MarketThe Cell and Gene Therapy CDMO Market is experiencing rapid transformation, with the market size projected to reach approximately USD 366.93 billion by 2035, highlighting an impressive CAGR of 23.53% from the current valuation of USD 35.89 billion in 2024. This substantial growth can be attributed to the rising demand for personalized medicine and advancements in production technologies. As...0 Commentarios 0 Acciones 301 Views 0 Vista previa
-
Vector Solutions: How Viral Vector CDMO Services Are Enabling Gene Therapy AdvancesThe Oncolytic Virus CDMO Services Market is experiencing robust growth as viral vector CDMO services continue to enable gene therapy advances and innovative cancer treatments. According to market reports, the global Oncolytic Virus CDMO Services Market was valued at USD 2,400 million in 2024 and is projected to reach USD 6.5 billion by 2035, exhibiting a CAGR of 9.6% during the...0 Commentarios 0 Acciones 169 Views 0 Vista previa
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Global Hemophilia Treatment Market by 2031: Growth Trends, Recent Developments, and Future OutlookThe Global Hemophilia Treatment Market is witnessing steady expansion driven by rising awareness, improved diagnostic capabilities, and continuous advancements in therapeutic options such as gene therapy and monoclonal antibodies. Hemophilia, a rare genetic bleeding disorder, requires lifelong management, which has significantly increased the demand for advanced and effective treatment...0 Commentarios 0 Acciones 796 Views 0 Vista previa
-
Rare Neurological Disease Treatment Market Competitive Landscape and Key PlayersThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Commentarios 0 Acciones 756 Views 0 Vista previa
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Commentarios 0 Acciones 1K Views 0 Vista previa
Resultados de la búsqueda
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek